Skip header and navigation

48 records – page 1 of 3.

Date Research Question / Title Unique ID Research Team
March 11, 2022 Do motivational interviewing (MI) techniques effectively address vaccine hesitancy? EOC220301 ESR EOC
December 26, 2021 How effective are COVID-19 vaccines? [Evergreen] INF031801v019 RR Infectious Disease
January 14, 2022 How effective are COVID-19 vaccines? [Evergreen] INF031801v020 ESR Infectious Disease
December 15, 2020 How is COVID-19 transmitted from person-to-person and what is the most common source of transmission? INF121501-01 ESR Infectious Disease
December 17, 2020 How is COVID-19 transmitted from person-to-person and what is the most common source of transmission? INF121501 RR Infectious Disease
May 2022 Motivational Interviewing for Vaccine Hesitancy - Situation, Background, Assessment, Recommendation (SBAR) EOC220301 SBAR EOC
March 11, 2022 What are long COVID's demands on the healthcare system, and its severity of the illness? EPM210602v2 ESR Epidemiology & Modelling
June 3, 2022 What are long COVID's demands on the healthcare system, and its severity of the illness? EPM210602v003 ESR Epidemiology & Modelling
June 20, 2022 What are long COVID's demands on the healthcare system, and its severity of the illness? EPM210602v002 RR Epidemiology & Modelling
March 11, 2021 What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)? EOC031001-01 ESR EOC
March 18, 2021 What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)? EOC031001 RR EOC
June 1, 2021 What are the ethical/legal aspects of vaccine requirements? EOC210503 ESR EOC
June 21, 2021 What are the ethical/legal aspects of vaccine requirements? EOC210503 RR EOC
April 1, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 ESR EOC
April 21, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 RR EOC
March 4, 2021 What are the vaccination strategies for vulnerable populations? PH030401-01 ESR Public Health
March 12, 2021 What are the vaccination strategies for vulnerable populations? PH030401 RR Public Health
September 17, 2020 What evidence is there to support medical exemptions for mask wearing? EOC091101 RR EOC
23-Apr-2020 What frequency of repeat population screening will be required? LAB042202-01 ESR Laboratory
April 25, 2020 What frequency of repeat population screening will be required? LAB042202 RR Laboratory

48 records – page 1 of 3.